Anne Windau

1.0k total citations
21 papers, 800 citations indexed

About

Anne Windau is a scholar working on Epidemiology, Pharmacology and Microbiology. According to data from OpenAlex, Anne Windau has authored 21 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Pharmacology and 6 papers in Microbiology. Recurrent topics in Anne Windau's work include Pneumonia and Respiratory Infections (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Respiratory viral infections research (6 papers). Anne Windau is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Respiratory viral infections research (6 papers). Anne Windau collaborates with scholars based in United States, Uganda and United Kingdom. Anne Windau's co-authors include Saralee Bajaksouzian, Michael R. Jacobs, Caryn E. Good, Peter C. Appelbaum, Robert A. Bonomo, Moses Joloba, David J. Ecker, M R Jacobs, William P. Hausdorff and Andrea Endimiani and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Anne Windau

21 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Windau United States	14	519	243	234	169	165	21	800
R. R. Reinert Germany	13	602 1.2×	161 0.7×	236 1.0×	114 0.7×	86 0.5×	18	767
Alan T. Evangelista United States	13	565 1.1×	242 1.0×	164 0.7×	119 0.7×	283 1.7×	27	759
Ryoji Yoshida Japan	10	356 0.7×	178 0.7×	224 1.0×	131 0.8×	129 0.8×	18	652
Thomas Man-kit So Thailand	6	432 0.8×	292 1.2×	128 0.5×	76 0.4×	120 0.7×	8	691
Carlos Fernández-Mazarrasa Spain	11	431 0.8×	200 0.8×	91 0.4×	262 1.6×	143 0.9×	15	715
A W Howell United States	13	506 1.0×	265 1.1×	213 0.9×	109 0.6×	254 1.5×	17	752
L A Maher United States	13	636 1.2×	288 1.2×	310 1.3×	147 0.9×	310 1.9×	18	897
Suchitha Bheemreddy United States	12	261 0.5×	318 1.3×	106 0.5×	197 1.2×	164 1.0×	13	642
M J Robbins United Kingdom	12	403 0.8×	190 0.8×	97 0.4×	110 0.7×	179 1.1×	19	728
Yolanda Mauriz United States	6	576 1.1×	291 1.2×	146 0.6×	179 1.1×	310 1.9×	7	765

Countries citing papers authored by Anne Windau

Since Specialization

Citations

This map shows the geographic impact of Anne Windau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Windau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Windau more than expected).

Fields of papers citing papers by Anne Windau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Windau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Windau. The network helps show where Anne Windau may publish in the future.

Co-authorship network of co-authors of Anne Windau

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Windau. A scholar is included among the top collaborators of Anne Windau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Windau. Anne Windau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raffay, Thomas M., et al.. (2024). Predictors of mortality and severe illness from Escherichia coli sepsis in neonates. Journal of Perinatology. 44(12). 1816–1821. 2 indexed citations

Windau, Anne, et al.. (2024). Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters. Microbiology Spectrum. 12(10). e0060524–e0060524. 2 indexed citations

Windau, Anne, et al.. (2022). SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays. Diagnostic Microbiology and Infectious Disease. 104(4). 115803–115803. 13 indexed citations

Pérez, Federico, Andrea Endimiani, Amy J. Ray, et al.. (2010). Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. Journal of Antimicrobial Chemotherapy. 65(8). 1807–1818. 156 indexed citations

Joloba, Moses, Benson R. Kidenya, David Patrick Kateete, et al.. (2010). Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes. International Journal of Antimicrobial Agents. 36(2). 124–128. 13 indexed citations

Jacobs, Michael R., Caryn E. Good, Anne Windau, et al.. (2010). Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States. Antimicrobial Agents and Chemotherapy. 54(6). 2716–2719. 61 indexed citations

Endimiani, Andrea, Federico Pérez, Saralee Bajaksouzian, et al.. (2010). Evaluation of Updated Interpretative Criteria for Categorizing Klebsiella pneumoniae with Reduced Carbapenem Susceptibility. Journal of Clinical Microbiology. 48(12). 4417–4425. 40 indexed citations

Jacobs, Michael R., Ron Dagan, Saralee Bajaksouzian, Anne Windau, & Nurith Porat. (2010). Validation of Factor 6d Antiserum for Serotyping Streptococcus pneumoniae Serotype 6C. Journal of Clinical Microbiology. 48(4). 1456–1457. 11 indexed citations

Jacobs, Michael R., Caryn E. Good, Saralee Bajaksouzian, & Anne Windau. (2008). Emergence ofStreptococcus pneumoniaeSerotypes 19A, 6C, and 22F and Serogroup 15 in Cleveland, Ohio, in Relation to Introduction of the Protein‐Conjugated Pneumococcal Vaccine. Clinical Infectious Diseases. 47(11). 1388–1395. 112 indexed citations

10.

Jacobs, Michael R., Caryn E. Good, Bernard Beall, et al.. (2008). Changes in Serotypes and Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Strains in Cleveland: a Quarter Century of Experience. Journal of Clinical Microbiology. 46(3). 982–990. 66 indexed citations

11.

Jacobs, Michael R., Saralee Bajaksouzian, Robert A. Bonomo, et al.. (2008). Occurrence, Distribution, and Origins of Streptococcus pneumoniae Serotype 6C, a Recently Recognized Serotype. Journal of Clinical Microbiology. 47(1). 64–72. 59 indexed citations

12.

Jacobs, Michael R., et al.. (2007). Nasopharyngeal Carriage of Respiratory Pathogens in Children Undergoing Pressure Equalization Tube Placement in the Era of Pneumococcal Protein Conjugate Vaccine Use. The Laryngoscope. 117(2). 295–298. 15 indexed citations

13.

Blossom, David B., Joan Nankya-Mutyoba, John Mukasa, et al.. (2006). Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility. International Journal of Infectious Diseases. 10(6). 458–464. 27 indexed citations

14.

Jacobs, Michael R., Saralee Bajaksouzian, Anne Windau, Elizabeth Palavecino, & Roslyn Yomtovían. (2005). Evaluation of the Scansystem method for detection of bacterially contaminated platelets. Transfusion. 45(2). 265–269. 29 indexed citations

15.

Koeth, Laura, Michael R. Jacobs, Caryn E. Good, et al.. (2004). Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000. International Journal of Infectious Diseases. 8(6). 362–373. 6 indexed citations

16.

Jacobs, Michael R., Saralee Bajaksouzian, Anne Windau, et al.. (2004). In Vitro Activity of the New Quinolone WCK 771 against Staphylococci. Antimicrobial Agents and Chemotherapy. 48(9). 3338–3342. 39 indexed citations

17.

Jacobs, Michael R., Saralee Bajaksouzian, Anne Windau, et al.. (2004). Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998–2001 U.S. Surveillance Study. Clinics in Laboratory Medicine. 24(2). 503–530. 35 indexed citations

18.

Goodman, Evan J., et al.. (2002). Clinically significant concentrations of local anesthetics inhibit Staphylococcus aureus in vitro. International Journal of Obstetric Anesthesia. 11(2). 95–99. 8 indexed citations

19.

Jacobs, Michael R., Saralee Bajaksouzian, Anne Windau, et al.. (2002). Effects of Various Test Media on the Activities of 21 Antimicrobial Agents against Haemophilus influenzae. Journal of Clinical Microbiology. 40(9). 3269–3276. 14 indexed citations

20.

Joloba, Moses, Anne Windau, Saralee Bajaksouzian, et al.. (2001). Pneumococcal Conjugate Vaccine Serotypes ofStreptococcus pneumoniaeIsolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis Media. Clinical Infectious Diseases. 33(9). 1489–1494. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact